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1210-l Acute and Long-Term Thromboembolic Events in 
Patients With Atrial Tachyarrhythmiae: Comparison 
Between Atrial Fibrillation, Atrial Flutter Plus Atrial 
Fibrillation, and Pure Atrial Flutter 
Karlheinz Seidl, Margit Vater, Monika Rameken. Axe1 Droegemueller, Andreas Brandt. 
Jochen Senges. Heart Center, Ludwigshafen. Germany 
Recent studies showed controversial results on the prevalence of atrial thrombi and the 
risk of thromboembolism (TE) after restoring sinus rhyihm in patients (pts) with atrial flut- 
ter (AFlut). Primary objective of this prospective observation1 study, performed on an 
intention to cardiovert basis, was to evaluate the thromboembolic event rate (TE) in pts 
with pure AFlut compared to pts with atrial fibrillation (AF). This study comprised 1639 pts 
(1269 pts with atrial fibrillation (AF), 206 pts with AFlut and AF, 362 pts with pure AFlut). 
Results: Transesophageal echocardiography was performed in 645 pts with AF and in 
209 pts with pure AFIut. Left atrial thrombi were detected in 65/845 pts with AF (7,7 %) 
compared to 61209 pts with Aflutt (3,8 %). Spontaneous echo contrast was observed in 
4291845 pts (51%) with AF compared to 43/209 pts (21%) with AFIut. Effective anticoag- 
ulation (INR 2-3) was obtained in 65% of pts with AF compared to 63% of pts with AF 
plus AFlut and 57% of pts with pure AFlut. Acute and longterm TE are listed in the table. 
Conclusiorxl) Transesophageal echo revealed 2 times more often left atrial thrombi in 
pts with pure AF compared to pure AFlut. 2) Pts with AF had 3 times more often a history 
of TE compared to pts with AFIut. 3) The thromboembolic event rate in between 4 weeks 
after cardioversion was not different between pts with AF compared to pts with AFlut. 4) 
During a long-term follow up thromboembolic events occurred 2 times more often in pts 
with AF plus AFlut. compared to pts with pure AF or pure AFlut. 
atrial fibrillation atrial flutter plus atrial pure atrial 
fibrillation flutter 
n 1269 pts 208 pts 362 pts 
history of TE 13411269 pts 18/208 pts (8.7%) 12/362 pts 
(10.6%) (3.3%) 
acute TE (< 48 h) 2/1269 pts 11208 pts (0.48%) l/362 pts 
(0.16%) (0.28%) 
TE~48h-4weeks 1 O/l 289 pts 2/208 pts (0.96%) 41362 pts 
(0.79%) (1.1%) 
long term (median 20 19/l 269 pts 71208 pts (3.36%) 5/362 pts 
months) (1.5%) (1.38%) 
overall TE 13% 13.5% 6.06% 
1210-2 Plasma von Willebrand Factor, Soluble 
Thrombomodulin, and Fibrin D-Dimer Levels in Acute- 
Onset Nonrheumatic Atrial Fibrillation 
Francisco Marin, Vanessa RoldBn, Vicente Climent, Alicia Ib&iez, Amaya Garcia. 
Pascual Marco, Francisco Sogorb, GreaorvY. Lie, General Hospital, Birmingham, Unlted 
Kingdom, Hospital General, Alicante, Spain 
Introduction. Despite the presence of a prothrombotic state in AF, most studies relate to 
the setting of chronic AF and few have prospectively assessed the presence of a pro- 
thrombotic state just after acute AF. Indeed, current treatment guidelines suggest that 
oral anticoagulation is not usually required in acute atrial fibrillation (AF) of ~48 hours’ 
duration. 
Methods. We recruited 24 patients with first onset acute non-rheumatic AF, in whom 
sinus rhythm was restored within 48 hours of arrhythmia onset, without anticoagulant 
therapy. Atrial mechanical function was assessed by transmitral inflow. We measured 
soluble thrombomodulin @TM) and van Willebrand factor (VWf) levels, as indices of 
endothelial damage/dysfunction; and fibrin D-dime, levels, as an index of thrombogene- 
sis. Blood samples and echocardiographic studies were performed at Days 1, 3. 7 and 
30 post-cardioversion. Research indices were compared with 24 healthy subjects, 24 
chronic AF patients and 24 ischaemic heart disease patients (IHD) in sinus rhythm. 
Results. Patients with AF (both acute and chronic) showed higher sTM, vWf and fibrin D- 
dime, levels, when compared with healthy controls and IHD patients (all ~~0.05). There 
were no significant differences in sTM and vWf levels between our ‘acute AF’ group and 
chronic AF. Higher fibrin D-dime, levels were found in patients with ‘acute AF’ compared 
with throw AF (p=O.O38). There were no statistically significant changes in echocardio- 
graphic parameters following cardioversion of acute AF (repeated measures ANOVA, all 
p=NS). 
Conclusions. In the absence of anticoagulation, patients after acute-onset AF demon- 
strate endothelial damage and increased thrombogenesis, which do not appear to be sig- 
nificantly altered in the 30 days of follow-up after successful cardioversion. 
1210-19 Paradoxical Increase in Strokes in the Randomized 
Trials on Rate Versus Rhythm Control in Atrial 
Freek W. A. Verheqt lsabelle C. van Gelder, D. George Wyse, Stefan Hohnloser, Joerg 
Carlsson, Harry J. Crijns, Heart Center, University Medical Center, Nijmegen, The 
Netherlands 
Background In patients with atrial fibrillation return to sinus rhythm is believed to 
decrease arrhythmic symptoms, heart failure and systemic embolism. In the past years 4 
major randomized trials on rate versus rhythm control have addressed these issues and 
their results have been published or presented. We specifically have analysed stroke 
prevention by a strategy of rhythm control. Results A total of 4,957 patients wth (parox- 
ysmal) atrial fibrillation were randomized in 4 trials to rate or rhythm control. Follow-up 
varied from 1 to 5 years. Oral anticoagulation was administered to almost all (94%) 
patients in the rate control strata and in all patients undergoing electrical cardioversion. 
The majority of rhythm control patients were anticoagulated during follow-up. Fig- 
ure.Unexpectedly, stroke is consistently increased in the rhythm control arms of the 4 tri- 
als compared to the rate control groups. Conclusion A routine strategy of rhythm control 
in (paroxysmal) atrial fibrillation tends to increase the stroke risk by nearly 30%. Besides 
the risk of side-effects of antiarrhythmics, the increased risk of stroke should be incorpo- 
rated in the decision to rhythm or rate control in atrial fibrillation. More extensive use of 
oral anticoagulants seems warranted, even when long-term sinus rhythm has been 
achieved. 
rate control rhythm control RR (95% Cl) P 
PIAF (n=252) 0.8% 0.8% 1.02 (0.73-2.16) 0.49 
STAF (n=286) 1 .O% 3.0% 3.01 (0.35-25.30) 0.52 
AFFIRM (n=4.917) 5.7% 7.3% 1.28 (0.95-l .72) 0.12 
RACE (n=522) 5.5% 7.9% 1.44 (0.75-2.78) 0.44 
total 5.0% 6.5% 1.28 (0.98-l .66) 0.08 
1210-20 Clinical Features of Minority Patients in the AFFIRM 
Study 
L. Julian Hawood, David E. Bush, Mary L. Chandler, and the AFFIRM Investigators, Los 
Angeles County/USC Medical Center. Los Angeles, CA 
Background: The AFFIRM Study showed no difference in survival from efforts to main- 
tain sinus rhythm, compared to rate control with anticoagulation, in patients with atrial 
fibrillation (AF) at high risk of stroke or death. We hypothesized that minority subgroups 
had different baseline clinical characteristics. Methods Baseline variables of patients in 
the AFFIRM Study were reviewed. Self-identified racial groups were: Caucasian (C), Afri- 
can-American (AA), Hispanic (H), and others. Results: 
N 
C AAH p+allIe p-value 
CvsAA CvsH 
3599 265 132 
Age 70.3 65.7 65.2 <O.OOOl <0.0001 
Female 38% 54% 40% <0.0001 0.63 
Coronary artery disease 27% 19% 26% <0.003 0.78 
Cardiomyopathy 5% 6% 9% 0.40 <O.Ol 
Lone AF 1% 3% 7% <0.0001 co.03 
Hypertension 49% 68% 52% <O.OOOi 0.51 
Congestive heart failure 22% 36% 34% <O.OOOl co.oo1 
Normal ejection fraction 69% 57% 56% <O.OOOl co.02 
Prior antiarrhylhmic drug failure 18% 11% 8% <0.004 <0.002 
First episode of AF 34% 50% 38% ~0.0001 0.41 
AF >48 hours 69% 71% 79% 0.53 <O.Ol 
Conclusions: Entry characteristics of the racial groups were different. Such differences 
could affect outcomes in minority patients with AF. 
